MCCOURT MARION 1663758 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-06-02 | 2023-06-01 | 2023-06-01 | 4 | Mccourt Marion | EVP COMMERCIAL | dsp | 250.0 | 1.2 | 0.02 | 736.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 20553.0 | 107.89 (REGN) |
2023-06-02 | 2023-06-01 | 4 | Mccourt Marion | EVP COMMERCIAL | holding | 157.0 | 0 | 0.01 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.89 (REGN) | ||
2023-08-03 | 2023-08-01 | 4 | Mccourt Marion | EVP COMMERCIAL | holding | 158.0 | 0 | 0.01 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.89 (REGN) | ||
2023-08-03 | 2023-08-01 | 2023-08-01 | 4 | Mccourt Marion | EVP COMMERCIAL | dsp | 250.0 | 1.23 | 0.02 | 744.66 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 20053.0 | 107.89 (REGN) |
2023-09-06 | 2023-09-01 | 2023-09-01 | 4 | Mccourt Marion | EVP COMMERCIAL | dsp | 250.0 | 1.25 | 0.02 | 834.55 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 19803.0 | 106.74 (REGN) |
2023-09-06 | 2023-09-01 | 4 | Mccourt Marion | EVP COMMERCIAL | holding | 158.0 | 0 | 0.01 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 106.74 (REGN) | ||
2023-10-03 | 2023-10-02 | 4 | Mccourt Marion | EVP COMMERCIAL | holding | 158.0 | 0 | 0.01 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 106.74 (REGN) | ||
2023-10-03 | 2023-10-02 | 2023-10-02 | 4 | Mccourt Marion | EVP COMMERCIAL | acq | 1038.0 | 4.98 | 0.1 | 372.46 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 20841.0 | 106.74 (REGN) |
2023-10-03 | 2023-10-02 | 2023-10-02 | 4 | Mccourt Marion | EVP COMMERCIAL | dsp | 1038.0 | 4.98 | 0.1 | 827.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 19803.0 | 106.74 (REGN) |
2023-11-02 | 2023-11-01 | 2023-11-01 | 4 | Mccourt Marion | EVP COMMERCIAL | acq | 1000.0 | 4.81 | 0.09 | 381.4 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 20803.0 | 106.74 (REGN) |
2023-11-02 | 2023-11-01 | 2023-11-01 | 4 | Mccourt Marion | EVP COMMERCIAL | dsp | 1000.0 | 4.81 | 0.09 | 783.91 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 19803.0 | 106.74 (REGN) |
2023-11-02 | 2023-11-01 | 4 | Mccourt Marion | EVP COMMERCIAL | holding | 158.0 | 0 | 0.01 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 106.74 (REGN) | ||
2023-12-12 | 2023-12-08 | 4 | Mccourt Marion | EVP COMMERCIAL | holding | 158.0 | 0 | 0.01 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
2023-12-12 | 2023-12-08 | 2023-12-08 | 4 | Mccourt Marion | EVP COMMERCIAL | acq | 2133.0 | 10.12 | 0.2 | 0.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code A | 21084.0 | 107.13 (REGN) |
2023-12-12 | 2023-12-08 | 2023-12-08 to 2023-12-11 | 4 | Mccourt Marion | EVP COMMERCIAL | dsp | 1495.0 | 6.82 | 0.14 | 842.9 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F S | 20441.0 | 107.13 (REGN) |
2023-12-14 | 2023-12-12 | 4 | Mccourt Marion | EVP COMMERCIAL | holding | 158.0 | 0 | 0.01 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
2023-12-14 | 2023-12-12 | 2023-12-12 | 4 | Mccourt Marion | EVP COMMERCIAL | dsp | 5105.0 | 24.97 | 0.48 | 856.71 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F | 15336.0 | 107.13 (REGN) |
2024-01-04 | 2024-01-02 | 4 | Mccourt Marion | EVP COMMERCIAL | holding | 158.0 | 0 | 0.01 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Mccourt Marion | EVP COMMERCIAL | dsp | 274.0 | 1.79 | 0.03 | 873.91 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 15062.0 | 107.13 (REGN) |
2024-02-02 | 2024-02-01 | 2024-02-01 | 4 | Mccourt Marion | EVP COMMERCIAL | dsp | 273.0 | 1.81 | 0.03 | 945.61 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 14789.0 | 107.13 (REGN) |
2024-02-02 | 2024-02-01 | 4 | Mccourt Marion | EVP COMMERCIAL | holding | 158.0 | 0 | 0.01 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
2024-02-06 | 2024-02-05 | 4 | Mccourt Marion | EVP COMMERCIAL | holding | 158.0 | 0 | 0.01 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
2024-02-06 | 2024-02-05 | 2024-02-05 | 4 | Mccourt Marion | EVP COMMERCIAL | dsp | 1000.0 | 6.76 | 0.09 | 934.71 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 13789.0 | 107.94 (REGN) |
2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Mccourt Marion | EVP COMMERCIAL | dsp | 358.0 | 2.6 | 0.03 | 967.5 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 13431.0 | 107.94 (REGN) |
2024-03-05 | 2024-03-01 | 4 | Mccourt Marion | EVP COMMERCIAL | holding | 158.0 | 0 | 0.01 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
2024-04-03 | 2024-04-01 | 4 | Mccourt Marion | EVP COMMERCIAL | holding | 158.0 | 0 | 0.01 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
2024-04-03 | 2024-04-01 | 2024-04-01 | 4 | Mccourt Marion | EVP COMMERCIAL | dsp | 250.0 | 1.86 | 0.02 | 964.73 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 13181.0 | 107.94 (REGN) |
2024-05-03 | 2024-05-01 | 4 | Mccourt Marion | EVP COMMERCIAL | holding | 174.0 | 0 | 0.02 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 108.37 (REGN) | ||
2024-05-03 | 2024-05-01 | 2024-05-01 | 4 | Mccourt Marion | EVP COMMERCIAL | dsp | 250.0 | 1.9 | 0.02 | 889.41 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 12931.0 | 108.37 (REGN) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-10-03 | 2023-10-02 | 2023-10-02 | 4 | Mccourt Marion | EVP COMMERCIAL | dsp | 1038.0 | 23.33 | 0.1 | 372.46 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 3412.0 | 106.74 (REGN) |
2023-11-02 | 2023-11-01 | 2023-11-01 | 4 | Mccourt Marion | EVP COMMERCIAL | dsp | 1000.0 | 10.0 | 0.09 | 381.4 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 9000.0 | 106.74 (REGN) |
2023-12-12 | 2023-12-08 | 2023-12-08 | 4 | Mccourt Marion | EVP COMMERCIAL | acq | 7649.0 | 100.0 | 0.71 | 843.79 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code A | 7649.0 | 107.13 (REGN) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)